Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review

(1) Background: The gut microbiota plays a crucial role in chronic immune activation associated with human immunodeficiency virus (HIV) infection, acquired immune deficiency syndrome (AIDS) pathogenesis, non-AIDS-related comorbidities, and mortality among people living with HIV (PLWH). The effects o...

Full description

Saved in:
Bibliographic Details
Main Authors: Zsófia Gáspár, Blin Nagavci, Bálint Gergely Szabó, Botond Lakatos
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/12/11/2221
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850266499629973504
author Zsófia Gáspár
Blin Nagavci
Bálint Gergely Szabó
Botond Lakatos
author_facet Zsófia Gáspár
Blin Nagavci
Bálint Gergely Szabó
Botond Lakatos
author_sort Zsófia Gáspár
collection DOAJ
description (1) Background: The gut microbiota plays a crucial role in chronic immune activation associated with human immunodeficiency virus (HIV) infection, acquired immune deficiency syndrome (AIDS) pathogenesis, non-AIDS-related comorbidities, and mortality among people living with HIV (PLWH). The effects of antiretroviral therapy on the microbiome remain underexplored. This study aims to map the evidence of the impact of integrase strand transfer inhibitors (INSTI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) on the gut microbiota of PLWH. (2) Methods: A scoping review was conducted using PubMed, Web of Science, and Embase, with reports collected following PRISMA for Scoping Reviews (PRISMA-ScR). (3) Results: Evidence suggests that INSTI-based regimes generally promote the restoration of alpha diversity, bringing it closer to that of seronegative controls, while beta diversity remains largely unchanged. INSTI-based therapies are suggested to be associated with improvements in microbiota composition and a tendency toward reduced inflammatory markers. In contrast, NNRTI-based treatments demonstrate limited recovery of alpha diversity and are linked to an increase in proinflammatory bacteria. (4) Conclusions: Based on the review of the current literature, it is indicated that INSTI-based antiretroviral therapy (ART) therapy facilitates better recovery of the gut microbiome.
format Article
id doaj-art-adbbe4b5de7d46f4bcb19149677e10d2
institution OA Journals
issn 2076-2607
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj-art-adbbe4b5de7d46f4bcb19149677e10d22025-08-20T01:54:08ZengMDPI AGMicroorganisms2076-26072024-11-011211222110.3390/microorganisms12112221Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping ReviewZsófia Gáspár0Blin Nagavci1Bálint Gergely Szabó2Botond Lakatos3National Institute of Hematology and Infectious Diseases, Central Hospital of Southern Pest, H-1097 Budapest, HungaryDoctoral School of Clinical Medicine, Semmelweis University, H-1097 Budapest, HungaryNational Institute of Hematology and Infectious Diseases, Central Hospital of Southern Pest, H-1097 Budapest, HungaryNational Institute of Hematology and Infectious Diseases, Central Hospital of Southern Pest, H-1097 Budapest, Hungary(1) Background: The gut microbiota plays a crucial role in chronic immune activation associated with human immunodeficiency virus (HIV) infection, acquired immune deficiency syndrome (AIDS) pathogenesis, non-AIDS-related comorbidities, and mortality among people living with HIV (PLWH). The effects of antiretroviral therapy on the microbiome remain underexplored. This study aims to map the evidence of the impact of integrase strand transfer inhibitors (INSTI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) on the gut microbiota of PLWH. (2) Methods: A scoping review was conducted using PubMed, Web of Science, and Embase, with reports collected following PRISMA for Scoping Reviews (PRISMA-ScR). (3) Results: Evidence suggests that INSTI-based regimes generally promote the restoration of alpha diversity, bringing it closer to that of seronegative controls, while beta diversity remains largely unchanged. INSTI-based therapies are suggested to be associated with improvements in microbiota composition and a tendency toward reduced inflammatory markers. In contrast, NNRTI-based treatments demonstrate limited recovery of alpha diversity and are linked to an increase in proinflammatory bacteria. (4) Conclusions: Based on the review of the current literature, it is indicated that INSTI-based antiretroviral therapy (ART) therapy facilitates better recovery of the gut microbiome.https://www.mdpi.com/2076-2607/12/11/2221AIDSacquired immunodeficiency syndromeHIVhuman immunodeficiency virusmicrobiomedysbiosis
spellingShingle Zsófia Gáspár
Blin Nagavci
Bálint Gergely Szabó
Botond Lakatos
Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review
Microorganisms
AIDS
acquired immunodeficiency syndrome
HIV
human immunodeficiency virus
microbiome
dysbiosis
title Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review
title_full Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review
title_fullStr Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review
title_full_unstemmed Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review
title_short Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review
title_sort gut microbiome alteration in hiv aids and the role of antiretroviral therapy a scoping review
topic AIDS
acquired immunodeficiency syndrome
HIV
human immunodeficiency virus
microbiome
dysbiosis
url https://www.mdpi.com/2076-2607/12/11/2221
work_keys_str_mv AT zsofiagaspar gutmicrobiomealterationinhivaidsandtheroleofantiretroviraltherapyascopingreview
AT blinnagavci gutmicrobiomealterationinhivaidsandtheroleofantiretroviraltherapyascopingreview
AT balintgergelyszabo gutmicrobiomealterationinhivaidsandtheroleofantiretroviraltherapyascopingreview
AT botondlakatos gutmicrobiomealterationinhivaidsandtheroleofantiretroviraltherapyascopingreview